
GRI
Healthcare · Biotechnology · $3.7M market cap
$1.70-0.12 (-6.6%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +22.9% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | After the close | -0.84 | -0.69 | +17.9% |
| Aug 14, 2026 | Before the open | -1.20 | -0.91 | +24.2% |
| May 13, 2026 | After the close | -3.74 | -1.61 | +57.0% |
| Jan 30, 2026 | Before the open | -29.26 | -116.61 | -298.5% |
| Nov 14, 2025 | Before the open | -31.08 | -35.84 | -15.3% |
| Aug 14, 2025 | Before the open | -36.68 | -36.68 | 0.0% |
| May 15, 2025 | Before the open | -105.98 | -5.80 | +94.5% |
| Mar 26, 2025 | After the close | -5.44 | -7.34 | -35.0% |
| Nov 14, 2024 | After the close | -347.48 | -318.92 | +8.2% |
| Aug 14, 2024 | Before the open | — | -4.92 | — |
| May 13, 2024 | Before the open | — | -3.10 | — |
| Feb 22, 2024 | Before the open | — | -3.10 | — |
| Nov 14, 2023 | After the close | — | -0.52 |
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as…
| — |
| Aug 8, 2023 | Time not confirmed | — | -4316.37 | — |
| May 10, 2023 | Time not confirmed | — | -5.33 | — |
| Feb 23, 2023 | Time not confirmed | -0.29 | -0.12 | +58.6% |
| Nov 3, 2022 | Time not confirmed | -0.25 | -0.09 | +64.0% |
| Jul 28, 2022 | Time not confirmed | -0.23 | -0.20 | +13.0% |
| May 9, 2022 | Time not confirmed | -0.22 | -0.22 | 0.0% |
| Feb 14, 2022 | Time not confirmed | -0.22 | -0.22 | 0.0% |
| Nov 12, 2021 | Time not confirmed | — | -0.18 | — |
| Sep 1, 2021 | Time not confirmed | — | -0.34 | — |
| May 13, 2021 | Time not confirmed | — | -0.46 | — |
| Jan 28, 2021 | Time not confirmed | — | -0.14 | — |
| Oct 23, 2020 | Time not confirmed | — | -0.19 | — |